RADIOPHARM THERANOSTICS LTD (RADX) Stock Earnings & Estimates
USA - NASDAQ:RADX - ADR
4.9958 USD
+0.47 (+10.28%)
4.58 USD
-0.42 (-8.32%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 292.4K | 299.2K 2.33% | 3.633M 1,114.37% | -100.00% | 7.769M | 49.267M 534.15% | 116.23M 135.92% | 181.2M 55.90% | 306.91M 69.38% | 502.4M 63.70% | |
| EBITDA YoY % growth | N/A -29.94% | N/A -79.58% | N/A 2.36% | -41.612M -2.49% | -25.856M 37.86% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.23M -71.87% | -37.123M -8.45% | -33.753M 9.08% | -64.376M -90.73% | -64.518M -0.22% | -36.246M 43.82% | 16.047M 144.27% | 60.043M 274.17% | 146.65M 144.24% | 307.18M 109.46% | |
| Operating Margin | -11,706.53% | -12,407.55% | -928.95% | N/A | -830.46% | -73.57% | 13.81% | 33.14% | 47.78% | 61.14% | |
| EPS YoY % growth | N/A 22.99% | N/A 20.65% | N/A 70.87% | -5.15 12.82% | -4.40 14.71% | -3.21 26.90% | 3.21 200.00% | 5.97 85.85% | 9.18 53.81% | 17.92 95.05% |
All data in AUD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -3.03 | -3.03 | -3.03 | -3.03 |
| Revenue Q2Q % growth | -100.00% | -100.00% | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.908M -57.68% | -29.691M -51.71% | N/A | N/A |
All data in AUD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -3.03 | % | ||
| Q2 2025 Q2Q % growth | 47.06% | -3.03 | % | |
| Q1 2025 Q2Q % growth | 47.06% | -3.03 | % | |
| Q4 2024 Q2Q % growth | 100.00% | 0.00 | % | |
| Q3 2024 Q2Q % growth | 47.06% | -3.03 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 2.25M 651.94% | 2.25M | % | |
| Q2 2024 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | 89.86% |
| Revenue | N/A | N/A | N/A | -100% |